Windlas Biotech Share Price

    NSE
    908
    -19.80 (2.07%)
    WINDLAS • 10 Jul, 2025 | 03:29 PM
    BUY

    1Y Annualised Return

    27.42%

    3Y Annualised Return

    60.37%

    The current prices are delayed, login or Open Demat Account for live prices.

    Windlas Biotech Stock Performance

    1W Return0.61
    1Y Return27.42
    Today's Low904.3
    Prev. Close927.80
    Mkt Cap (Cr.)1,899.42
    1M Return-1.65
    3Y Return311.13
    52-Week High1198.25
    Open939.65
    PE Ratio31.33
    6M Return-8.09
    Today's High947.2
    52-Week Low659
    Face Value5

    Windlas Biotech Company background

    Founded in: 2001
    Managing director: Hitesh Windlass
    Windlas Biotech Limited (formerly known as Windlas Biotech Private Limited) was incorporated in 2001. The Company convertedfrom a Private Limited Company to a Public Limited Company and the name of the Company was changed to Windlas Biotech Limited. A fresh Certificate of Incorporation dated April 15, 2021, granted by the Registrar of Companies, Uttarakhand at Dehradun.The Company is engaged in manufacturing and trading of pharmaceutical products. TheIR manufacturing facilities are located at Dehradun in Uttarakhand. It also has a sales force and distribution network spread across 14 states. The company market its own manufactured authentic nutraceutical, pharmaceutical and Ayurvedic products to serve the semiurban and rural communities at affordable prices. Apart from this, the company has three distinct strategic business verticals (SBVs) mainly comprising of CDMO services and products domestic trade generics and overthecounter (OTC) brands and exports.The Company commenced operations at Dehradun Plant IV in 2010. It provides a comprehensive range of CDMO services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics, in compliance with current Good Manufacturing Practices (GMP) with a focus on improved safety, efficacy and cost. In addition to this, it sells its own branded products in the trade generics and OTC markets as well as export generic products to several countries. The company focused on developing and launching new complex generic products containing APIs which are difficult to handle or formulate. It needs pairing with a device to make a drugdevice combo primarily in solid and liquid pharmaceutical dosage forms to provide specialized capabilities to customers especially for high potency, controlled substances and lowsolubility products. Further, the development and manufacturing of complex generic products typically involves a higher degree of expertise/ trained manpower and utilizes higher overall process times. Its complex generic products portfolio primarily comprises fixed dosage combinations, fixed dosage plus modified release combinations, customized generics and chewable or dispersible. In 2020, the Company acquired the erstwhile associate Windlas Healthcare.To conclude, the company has introduced high quality systems across its manufacturing facilities that cover the full product lifecycle from process innovation and RD, through the stages of process development, manufacturing, sales, and supply chain, to the customer evaluation of products as well as management systems for ensuring consistent quality, efficacy, and safety of products. And hence forth, the company identifies and approves multiple vendors to source the raw materials pursuant to robust vendor assessment, in addition to the suppliers approved by its customers.In August 2021, the Company made an Initial Public Offer of 8,729,023 Equity Shares by raising capital from public aggregating to Rs 401.53 Crore, comprising a Fresh Issue of 3,586,956 Equity Shares aggregating to Rs 165 Crore and an Offer for Sale of 5,142,067 Equity Shares aggregating to Rs 236.53 Crore.

    As of 10 Jul, 2025, Windlas Biotech share price is ₹908.8. The stock opened at ₹939.6 and had closed at ₹927.8 the previous day. During today’s trading session, Windlas Biotech share price moved between ₹904.30 and ₹947.20, with an average price for the day of ₹925.75. Over the last 52 weeks, the stock has recorded a low of ₹659.00 and a high of ₹1,198.25. In terms of performance, Windlas Biotech share price has declined by 8.1% over the past six months and has increased by 27.42% over the last year.

    Read More
    Windlas Biotech SIP Return Calculator

    Over the past

    1 year
    3 years
    Total Investment of ₹65,00,000
    Would have become ₹74,81,882 (+15.11%)
    Daily SIP of 25,000 would have become 74,81,882 in 1 year with a gain of 9,81,882 (+15.11%)
    View details of Market Depth

    Windlas Biotech Fundamental

    Market Cap (in crs)

    1,899.42

    Face Value

    5

    Turnover (in lacs)

    489.10

    Key Metrics

    Qtr Change %
    37.91% Gain from 52W Low
    1.8
    Dividend yield 1yr %
    Above industry Median
    0.6

    Windlas Biotech Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Windlas Biotech Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    202.7 Cr
    195.02 Cr
    187 Cr
    175.15 Cr
    171.28 Cr
    Windlas Biotech Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    777.9 Cr
    644.42 Cr
    523.05 Cr
    472.64 Cr
    430.7 Cr
    331.34 Cr
    Windlas Biotech Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    16.28 Cr
    15.58 Cr
    15.66 Cr
    13.48 Cr
    16.99 Cr
    Windlas Biotech Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    60.99 Cr
    58.19 Cr
    42.63 Cr
    38.09 Cr
    15.74 Cr
    23.68 Cr

    Windlas Biotech Result Highlights

    • Windlas Biotech Ltd reported a 11.8% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 22.8%.

    • Its expenses for the quarter were down by 14.4% QoQ and up 19.6% YoY.

    • The net profit increased 9.1% QoQ and increased 48.5% YoY.

    • The earnings per share (EPS) of Windlas Biotech Ltd stood at 8.1 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Windlas Biotech

    Promoter
    62.3%
    Foreign Institutions
    1.5%
    Mutual Funds
    6.7%
    Domestic Institutions
    10.9%
    Public
    25.2%
    Promoter
    62.5%
    Foreign Institutions
    1.6%
    Mutual Funds
    7.1%
    Domestic Institutions
    10.2%
    Public
    25.7%
    Promoter
    62.5%
    Foreign Institutions
    2%
    Mutual Funds
    7.6%
    Domestic Institutions
    9.6%
    Public
    25.9%
    Promoter
    62.5%
    Foreign Institutions
    1.6%
    Mutual Funds
    8.7%
    Domestic Institutions
    10.3%
    Public
    25.6%
    Promoter
    62.8%
    Foreign Institutions
    1.2%
    Mutual Funds
    10.4%
    Domestic Institutions
    11.8%
    Public
    24.2%
    Promoter
    62.8%
    Foreign Institutions
    1.4%
    Mutual Funds
    10.4%
    Domestic Institutions
    11.7%
    Public
    24.1%

    Windlas Biotech Technical Analysis

    Moving Averages Analysis
    908
    Current Price
    Bullish Moving Averages
    9
    Bearish Moving Averages
    7
    5Day EMA
    908.70
    10Day EMA
    905.30
    12Day EMA
    904.90
    20Day EMA
    906.90
    26Day EMA
    910.10
    50Day EMA
    922.80
    100Day EMA
    933.50
    200Day EMA
    906.30
    5Day SMA
    907.80
    10Day SMA
    902.20
    20Day SMA
    901.90
    30Day SMA
    907.30
    50Day SMA
    929.60
    100Day SMA
    926.50
    150Day SMA
    956.10
    200Day SMA
    960.70
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    27152 Rs
    56395 Rs
    Week Rs
    22016 Rs
    43426 Rs
    Month Rs
    22106 Rs
    43983 Rs
    920.10
    Pivot
    Resistance
    First Resistance
    935.90
    Second Resistance
    963
    Third Resistance
    978.80
    Support
    First Support
    893
    Second support
    877.20
    Third Support
    850.10
    Relative Strength Index
    49.39
    Money Flow Index
    52.27
    MACD
    -5.20
    MACD Signal
    -9.33
    Average True Range
    31.02
    Average Directional Index
    14.72
    Rate of Change (21)
    -1.65
    Rate of Change (125)
    -13.91
    Name
    Holding Percent
    Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) Fund
    5.97
    Perpetuity Health To Wealth (H2w) Rising Fund
    1.29
    Persistence Capital Fund I
    1.09
    PGIM India Equity Growth Opportunities Fund-Series I
    1.02

    Windlas Biotech Latest News

    09 JUL 2025 | Wednesday

    Windlas Biotech Ltd - 543329 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    06 JUL 2025 | Sunday

    Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    05 JUL 2025 | Saturday

    Windlas Biotech Ltd - 543329 - Intimation Of Cut-Off Date And E-Voting

    View More

    Windlas Biotech Share Price FAQs

    Windlas Biotech share price is ₹908 in NSE and ₹910.5 in BSE as on 10/7/2025.

    Windlas Biotech share price in the past 1-year return was 27.41. The Windlas Biotech share hit a 1-year low of Rs. 659 and a 1-year high of Rs. 1198.25.

    The market cap of Windlas Biotech is Rs. 1899.42 Cr. as of 10/7/2025.

    The PE ratios of Windlas Biotech is 31.33 as of 10/7/2025.

    The PB ratios of Windlas Biotech is 3.75 as of 10/7/2025

    The Mutual Fund Shareholding in Windlas Biotech was 6.7% at the end of 10/7/2025.

    You can easily buy Windlas Biotech shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Windlas Biotech share price is ₹1198.25 and ₹659 as of 10/7/2025.

    Please be aware that Windlas Biotech stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    65.97
    +0.03 (+0.05%)
    137.13
    -0.46 (-0.33%)
    695.60
    +2.80 (+0.40%)
    2,581.00
    -2.00 (-0.08%)
    169.64
    +3.73 (+2.25%)
    384.70
    -0.40 (-0.10%)
    160.66
    +1.66 (+1.04%)
    262.85
    -1.70 (-0.64%)
    0.00
    0.00 (0.00%)
    399.90
    -0.75 (-0.19%)
    Top Gainers
    12,650.00
    +180.00 (+1.44%)
    852.85
    +12.10 (+1.44%)
    160.66
    +1.66 (+1.04%)
    947.65
    +7.05 (+0.75%)
    2,039.40
    +13.00 (+0.64%)
    Top Losers
    1,964.50
    -55.20 (-2.73%)
    771.25
    -15.05 (-1.91%)
    2,451.20
    -47.70 (-1.91%)
    7,359.00
    -110.00 (-1.47%)
    671.75
    -9.30 (-1.37%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -